IHH Healthcare Berhad: Substantial Shareholder Lowers Indirect Stake

SGX Filings

Dec 24, 2025

IHH Healthcare Berhad announced on Dec, 24 2025 that substantial shareholder Mrs. Hatice Seher Aydinlar has reduced her indirect shareholding in the company.

Mrs. Aydinlar disposed of 750,000 ordinary shares on Dec, 22 2025 and a further 750,000 shares on Dec, 23 2025 through open-market transactions executed via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA.

Following the sales, Mrs. Aydinlar’s direct holding remains at 7,000,000 ordinary shares, representing 0.079 % of issued shares. Her indirect/deemed interest stands at 509,273,473 shares, or 5.764 %. In aggregate, she now controls 516,273,473 ordinary shares in IHH Healthcare Berhad.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1129019546"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129019546\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129019546?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-24 18:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129019546","market":"sg","top_or_hot":-1,"title":"IHH Healthcare Berhad: Substantial Shareholder Lowers Indirect Stake","media":"SGX Filings","content":"<p>IHH Healthcare Berhad announced on Dec, 24 2025 that substantial shareholder Mrs. Hatice Seher Aydinlar has reduced her indirect shareholding in the company.</p>\n<p>Mrs. Aydinlar disposed of 750,000 ordinary shares on Dec, 22 2025 and a further 750,000 shares on Dec, 23 2025 through open-market transactions executed via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA.</p>\n<p>Following the sales, Mrs. Aydinlar’s direct holding remains at 7,000,000 ordinary shares, representing 0.079 % of issued shares. Her indirect/deemed interest stands at 509,273,473 shares, or 5.764 %. In aggregate, she now controls 516,273,473 ordinary shares in IHH Healthcare Berhad.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Berhad: Substantial Shareholder Lowers Indirect Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Berhad: Substantial Shareholder Lowers Indirect Stake\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2025-12-24 18:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IHH Healthcare Berhad announced on Dec, 24 2025 that substantial shareholder Mrs. Hatice Seher Aydinlar has reduced her indirect shareholding in the company.</p>\n<p>Mrs. Aydinlar disposed of 750,000 ordinary shares on Dec, 22 2025 and a further 750,000 shares on Dec, 23 2025 through open-market transactions executed via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA.</p>\n<p>Following the sales, Mrs. Aydinlar’s direct holding remains at 7,000,000 ordinary shares, representing 0.079 % of issued shares. Her indirect/deemed interest stands at 509,273,473 shares, or 5.764 %. In aggregate, she now controls 516,273,473 ordinary shares in IHH Healthcare Berhad.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"Q0F.SI","symbol_name":"IHH医疗保健集团","start_time":0,"source_url":"","article_id":"1129019546","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129019546","pubTimestamp":1766570825,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"IHH Healthcare Berhad announced on Dec, 24 2025 that substantial shareholder Mrs. Hatice Seher Aydinlar has reduced her indirect shareholding in the company. Mrs. Aydinlar disposed of 750,000...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"Q0F.SI":"IHH医疗保健集团"},"translate_title":"IHH Healthcare Berhad：大股东减持间接股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"Q0F.SI":1},"content_text":"IHH Healthcare Berhad announced on Dec, 24 2025 that substantial shareholder Mrs. Hatice Seher Aydinlar has reduced her indirect shareholding in the company.\nMrs. Aydinlar disposed of 750,000 ordinary shares on Dec, 22 2025 and a further 750,000 shares on Dec, 23 2025 through open-market transactions executed via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA.\nFollowing the sales, Mrs. Aydinlar’s direct holding remains at 7,000,000 ordinary shares, representing 0.079 % of issued shares. Her indirect/deemed interest stands at 509,273,473 shares, or 5.764 %. In aggregate, she now controls 516,273,473 ordinary shares in IHH Healthcare Berhad.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}